Straumann saw the highest growth of 0.99% in patent filings in April and 1.49% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and grants by 0.66%. GlobalData’s DataBook provides a comprehensive analysis of Straumann‘s patent filings and grants. Buy the databook here.
Straumann has been focused on protecting inventions in Spain(ES) with six publications in Q2 2024
The Spain(ES) Patent Office dominates the patent grants with nearly 43% of grants. The United States(US), European Patent Office(EPO), World Intellectual Property Organization(WIPO), and Germany(DE) patent Office are among the top ten patent offices where Straumann is filings its patents. Among the top granted patent authorities, Straumann has 43% of its grants in Spain(ES), 21% in United States(US) and 14% in European Patent Office(EPO).
Osstem Implant could be the strongest competitor for Straumann
Patents related to healthtech lead Straumann's portfolio
Straumann has the highest number of patents in healthtech. For healthtech, nearly 100% of patents were filed and no patents were granted in Q2 2024.
Dental devices related patents lead Straumann portfolio followed by grouts and mortars, and orthopedic devices
Straumann has highest number of patents in dental devices followed by grouts and mortars, orthopedic devices, diagnostic imaging, and image management. For dental devices, nearly 67% of patents were filed and 75% of patents were granted in Q2 2024.
For comprehensive analysis of Straumann's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.